112242 ⎘
Vectors comprising a targeting moiety; Vectors comprising as targeting moiety peptide derived from defined protein from viruses ssDNA viruses
ENGINEERED MUSCLE TARGETING COMPOSITIONS
#2ENGINEERED MUSCLE TARGETING COMPOSITIONS
#3ENGINEERED MUSCLE TARGETING COMPOSITIONS
#4AAV Vectors Targeted to Oligodendrocytes
#5METHODS AND COMPOSITIONS FOR DECREASING CHRONIC PAIN
#6Recombinant Adeno-Associated Vectors For Targeted Treatment
#7VIRAL VECTOR FOR THE TARGETED TRANSFER OF GENES IN THE BRAIN AND SPINAL CORD
#8Compositions and Methods for Altering Tissue Specificity and Improving AAV9-Mediated Gene Transfer
#9METHODS TO PRODUCE CHIMERIC ADENO-ASSOCIATED VIRUS/BOCAVIRUS PARVOVIRUS
#10NIPAH VIRUS ENVELOPE PSEUDOTYPED LENTIVIRUSES AND METHODS OF THEIR USE
#11CAPSID-MODIFIED RAAV VECTOR COMPOSITIONS AND METHODS THEREFOR
#12ENGINEERED MUSCLE TARGETING COMPOSITIONS
#13ADENO-ASSOCIATED VIRAL VECTORS USEFUL IN TREATMENT OF SPINAL MUSCULAR ATROPY
#14Engineered muscle targeting compositions
#15Composition for treatment of Crigler-Najjar syndrome
#16SYSTEMS FOR EVOLVED ADENO-ASSOCIATED VIRUSES (AAVS) FOR TARGETED DELIVERY
#17Selective recovery
#18Methods and compositions for antibody-evading virus vectors
#19NOVEL AAV8 MUTANT CAPSIDS AND COMPOSITIONS CONTAINING SAME
#20CAPSID-MODIFIED, RAAV3 VECTOR COMPOSITIONS AND METHODS OF USE IN GENE THERAPY OF HUMAN LIVER CANCER
#21Variant adeno-associated viruses and methods of using
#22COMPOSITIONS FOR TARGETING CONDUCTING AIRWAY CELLS COMPRISING ADENO-ASSOCIATED VIRUS CONSTRUCTS
#23VIRAL VECTOR FOR THE TARGETED TRANSFER OF GENES IN THE BRAIN AND SPINAL CORD
#24Compositions and methods for altering tissue specificity and improving AAV9-mediated gene transfer
#25Methods to produce chimeric adeno-associated virus/bocavirus parvovirus
#26Methods and compositions for decreasing chronic pain
#27CAPSID-MODIFIED RAAV VECTORS AND METHODS OF USE
#28Recombinant adeno-associated vectors for targeted treatment
#29Methods and compositions for antibody-evading virus vectors
#30Synthetic combinatorial AAV3 capsid library
#31Compositions and methods for altering tissue specificity and improving AAV9-mediated gene transfer
#32Selective recovery
#33Recombinant AAV variants and uses thereof
#34AAV vectors targeted to oligodendrocytes
#35Variant adeno-associated viruses and methods of using
#36Selective recovery
#37Viral vector for the targeted transfer of genes in the brain and spinal cord
#38Selective recovery
#39CAPSID-MODIFIED RAAV VECTOR COMPOSITIONS AND METHODS THEREFOR
#40Nipah virus envelope pseudotyped lentiviruses and methods of their use
#41AAV8 mutant capsids and compositions containing same
#42Methods and compositions for antibody-evading virus vectors
#43Capsid-modified rAAV vector compositions and methods therefor
#44Composition for treatment of Crigler-Najjar syndrome
#45ADENO-ASSOCIATED VIRAL VECTORS USEFUL IN TREATMENT OF SPINAL MUSCULAR ATROPY
#46Chimeric adeno-associated virus/ bocavirus parvovirus vector
#47CAPSID-MODIFIED RAAV VECTOR COMPOSITIONS HAVING IMPROVED TRANSDUCTION EFFICIENCIES, AND METHODS OF USE
#48Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
#49Modification of n-terminal region of capsid proteins for enhanced properties of adeno-associated viruses
#50Selective recovery
#51Capsid-modified, RAAV3 vector compositions and uses in gene therapy of human liver cancer
#52Compositions and methods for altering tissue specificity and improving AAV9-mediated gene transfer
#53Recombinant adeno-associated vectors for targeted treatment
#54AAV vectors with high transduction efficiency and uses thereof for gene therapy
#55Viral vectors for the treatment of retinal dystrophy
#56Compositions and methods for treating diseases
#57Capsid modified rAAV vectors and methods of use
#58Recombinant AAV variants and uses thereof
#59AAV Vectors Targeted to Oligodendrocytes
#60Selective recovery
#61Recombinant adeno-associated vectors for targeted treatment
#62Recombinant adeno-associated vectors for targeted treatment
#63Recombinant adeno-associated vectors for targeted treatment
#64Recombinant adeno-associated vectors for targeted treatment
#65Viral vector for the targeted transfer of genes in the brain and spinal cord
#66rAAV vectors and methods for transduction of photoreceptors and RPE cells
#67Compositions and methods for treating diseases
#68Adeno-associated vectors for enhanced transduction and reduced immunogenicity
#69Viral vectors for the treatment of retinal dystrophy
#70Chimeric adeno-associated virus/ bocavirus parvovirus vector
#71Recombinant adeno-associated vectors for targeted treatment
#72AAV vectors targeted to oligodendrocytes
#73Modified virus vectors and methods of making and using the same
#74Mutant adeno-associated virus virions and methods of use thereof
#75Recombinant AAV capsid protein
#76Nipah virus envelope pseudotyped lentiviruses and methods of their use
#77Capsid-modified rAAV vector compositions and methods therefor
#78Capsid-modified rAAV vector compositions having improved transduction efficiencies, and methods of use
#79Viral vectors for the treatment of retinal dystrophy
#80Compositions and methods for altering tissue specificity and improving AAV9-mediated gene transfer
#81Adeno-associated virus 2/8—micro RNA-101 therapy for liver cancer
#82Methods of increasing efficiency of vector penetration of target tissue
#83Recombinant adeno-associated vectors for targeted treatment
#84Compositions and Methods for Treating Diseases
#85Compositions for targeting conducting airway cells comprising adeno-associated virus constructs
#86Modified virus vectors and methods of making and using the same
#87CD34-derived recombinant adeno-associated vectors for stem cell transduction and systemic therapeutic gene transfer
#88METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROLOGICAL DISEASE
#89Tyrosine-modified recombinant rAAV vector compositions and methods for use
#90Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
#91Mutant adeno-associated virus virions and methods of use thereof
#92Modified baculovirus expression system for production of pseudotyped rAAV vector
#93Methods and compositions for the treatment of neurological disease